Drug Profile
Estriol succinate vaginal gel - Italfarmaco
Alternative Names: 6α-hydroxyestradiol; Blissel; estra-1,3,5(10)-triene-3,16α,17β-triol; GelistrolLatest Information Update: 07 Dec 2022
Price :
$50
*
At a glance
- Originator Italfarmaco
- Class Estrenes; Hormonal replacements
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Atrophic vaginitis
Most Recent Events
- 07 Dec 2022 No development reported - Phase-II for Atrophic vaginitis in Italy, Spain, Sweden, Hungary, Czech Republic (Vaginal) prior to December 2022 (NCT02967510)
- 04 Oct 2018 Phase-III clinical trials in Atrophic vaginitis in Spain (Vaginal) (EudraCT2018-001481-42)
- 01 May 2018 Italfarmaco completes a phase II trial for Atrophic vaginitis in Sweden, Spain, Czech Republic, Hungary and Italy (Vaginal, Gel, 0.005%, 0.002% and 0.0008%) (NCT02967510)